Mankind Pharma Sees 17.86% Surge in Open Interest to 13,265 Contracts

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a significant increase in open interest (OI) today. The latest OI stands at 13,265 contracts, reflecting a rise of 2,010 contracts or 17.86% from the previous OI of 11,255. This uptick in OI comes alongside a trading volume of 8,196 contracts, indicating heightened activity in the derivatives market. Despite this surge in open interest, Mankind Pharma's stock has underperformed, showing a decline of 1.89% today, compared to a sector return of -0.53%. The stock has been on a downward trend, losing 3.23% over the past two days. It reached an intraday low of Rs 2,315, down 2.3% from the previous close. The weighted average price suggests that more volume was traded closer to this low price, indicating a potential shift in trading dynamics. Additionally, the stock is currently trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, highlighting a bearish trend. However, there has been a notable increase in delivery volume, which rose by 71.95% against the 5-day average, suggesting a rise in investor participation. Overall, the increase in open interest amidst a challenging trading environment underscores the evolving market conditions for Mankind Pharma.